SCHEMBL7974492

SCHEMBL7974492

CC(C)(C)c1ccc(Cn2cnc3[nH]c(-c4ccccc4)nc(=O)c32)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCC8 Q09428 1/20 0.47
KCNJ11 Q14654 1/20 0.47
PARN O95453 1/20 0.46
CNOT7 Q9UIV1 1/20 0.46
TNKS O95271 1/20 0.43
TNKS2 Q9H2K2 1/20 0.43
NR1H4 Q96RI1 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
NR1I2 O75469 1/20 0.40
ADORA2B P29275 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
METAP2 P50579 1/20 0.40
PDE2A O00408 2/20 0.39
HPGD P15428 1/20 0.39
P2RX7 Q99572 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984934 0.90 CNOT7 (0.47) ABCC8KCNJ11PARNCNOT7TNKS
SCHEMBL7988524 0.90 ABCC8 (0.47) ABCC8KCNJ11PARNCNOT7TNKS
SCHEMBL7987364 0.89 TNKS (0.46) ABCC8KCNJ11PARNCNOT7TNKS
SCHEMBL7987953 0.89 PDE2A (0.46) PARNCNOT7TNKSTNKS2SMN1; SMN2
SCHEMBL7985012 0.89 ABCC8 (0.43) ABCC8KCNJ11PARNCNOT7NR1H4
SCHEMBL7991403 0.89 ABCC8 (0.43) ABCC8KCNJ11PARNCNOT7NR1H4
SCHEMBL7974239 0.89 CNOT7 (0.45) ABCC8KCNJ11PARNCNOT7NR1H4
SCHEMBL7975271 0.89 CNOT7 (0.56) PARNCNOT7SMN1; SMN2ADORA2BRXFP1
SCHEMBL7984871 0.89 ABCC8 (0.45) ABCC8KCNJ11PARNCNOT7TNKS
SCHEMBL8056964 0.88 CNOT7 (0.47) ABCC8KCNJ11PARNCNOT7SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed